Adicet Bio, Inc.
ACET
$0.537
$0.089920.11%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.75% | -1.93% | -6.73% | 5.00% | 40.89% |
| Total Depreciation and Amortization | 1.95% | -0.62% | -2.97% | -2.25% | 2.67% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | 3,800.00% | 0.00% |
| Total Other Non-Cash Items | -56.04% | 7.40% | 5.28% | 13.90% | -78.01% |
| Change in Net Operating Assets | 50.95% | 78.13% | 35.55% | -119.85% | -210.07% |
| Cash from Operations | -9.52% | 6.05% | -2.51% | 2.71% | -10.58% |
| Capital Expenditure | 56.11% | -32.78% | -26.36% | -75.74% | 84.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -29,401.25% | -32.78% | -26.36% | -75.74% | 84.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -99.82% | 70,668.79% | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -74.07% | -37.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 200.14% | -47,247.06% | -99.82% | 145,907.89% | 228.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 61.14% | -404.20% | -126.76% | 473.22% | -6.05% |
